Aspen Aerogels (NYSE:ASPN) Upgraded at StockNews.com

by · The Markets Daily

StockNews.com upgraded shares of Aspen Aerogels (NYSE:ASPN – Free Report) to a sell rating in a report published on Wednesday.

Several other research analysts also recently weighed in on ASPN. Canaccord Genuity Group dropped their target price on shares of Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating for the company in a report on Friday, February 14th. Barclays dropped their price objective on Aspen Aerogels from $27.00 to $25.00 and set an “overweight” rating for the company in a research note on Tuesday, November 12th. Roth Mkm decreased their target price on Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating on the stock in a research note on Friday, February 14th. Piper Sandler lowered their price target on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. Finally, Seaport Res Ptn lowered shares of Aspen Aerogels from a “strong-buy” rating to a “hold” rating in a report on Wednesday, February 12th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $22.44.

Read Our Latest Analysis on Aspen Aerogels

Aspen Aerogels Stock Down 1.4 %

ASPN stock opened at $8.04 on Wednesday. The business’s 50-day moving average price is $11.75 and its 200-day moving average price is $18.15. The stock has a market cap of $659.27 million, a P/E ratio of 50.22 and a beta of 2.14. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. Aspen Aerogels has a twelve month low of $7.96 and a twelve month high of $33.15.

Aspen Aerogels (NYSE:ASPN – Get Free Report) last issued its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a net margin of 2.95% and a return on equity of 7.49%. On average, equities research analysts forecast that Aspen Aerogels will post 0.22 EPS for the current year.

Institutional Trading of Aspen Aerogels

Hedge funds have recently modified their holdings of the company. Sandia Investment Management LP purchased a new position in shares of Aspen Aerogels in the fourth quarter valued at $89,000. AlphaQuest LLC lifted its position in Aspen Aerogels by 54.0% during the fourth quarter. AlphaQuest LLC now owns 11,395 shares of the construction company’s stock valued at $135,000 after purchasing an additional 3,998 shares during the last quarter. KLP Kapitalforvaltning AS purchased a new position in shares of Aspen Aerogels in the 4th quarter worth $164,000. Connors Investor Services Inc. bought a new stake in shares of Aspen Aerogels in the 4th quarter worth about $168,000. Finally, Journey Strategic Wealth LLC purchased a new stake in shares of Aspen Aerogels during the 4th quarter valued at about $178,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

About Aspen Aerogels

(Get Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Read More